👁 1
💬 0
📄 Extracted Text (592 words)
American Farmland Company
Notes to Consolidated Financial Statements (Continued)
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
the lease. Should a tenant terminate its lease, the unamortized portion of any above-market and below-
market lease values, in-place lease values and any associates intangibles will be immediately charged to
the related income or expense.
We account for the impairment of real estate, including intangible assets, in accordance with
ASC 360-10-35, "Property, Plant, and Equipment," which requires us to periodically review the carrying
value of each property to determine whether circumstances indicate impairment of the carrying value of
the investment exists or if depreciation periods should be modified. If circumstances support the
possibility of impairment, we prepare a projection of the undiscounted future cash flows, without
interest charges, of the specific property and determine whether the carrying value of the investment in
such property is recoverable. In performing the analysis, we consider such factors as agricultural and
business conditions in the regions in which our farms are located, and the development period (if
applicable), and whether there are indications that the fair value of the real estate has decreased. If the
carrying amount is more than the aggregate undiscounted future cash flows, we would recognize an
impairment loss to the extent the carrying amount exceeds the estimated fair value of the property.
We evaluate our entire property portfolio each quarter for any impairment indicators and perform
an impairment analysis. We concluded that none of our properties were impaired as of December 31,
2014 or 2013 and we will continue to monitor our portfolio for any indicators of impairment. There
have been no impairments recognized on real estate assets since our inception.
Stock—There were 300,000,000 shares of common stock, par value $0.01 per share, authorized
with 10,436,902 issued and outstanding as of December 31, 2014 and 10,444,584 shares issued and
10,039,384 shares outstanding as of December 31, 2013. There were 35 8% Series A Cumulative
Non-Voting Preferred Stock, par value $0.01 per share, authorized as of December 31, 2014 and
December 31. 2013 with 29 issued and outstanding as of those dates.
Non-Controlling Interests—Non-controlling interest is the portion of capital in the Operating
Partnership not attributable to the Company. Our non-controlling interests relates to the Founders'
capital accounts and the de minimis capital account of AFA in the Operating Partnership.
Non-controlling interests are reported in equity on the consolidated balance sheets but separate from
the Company's stockholders' equity. On the consolidated statements of operations, the Operating
Partnership is reported at the consolidated amount, including both the amount attributable to the
Company and non-controlling interests.
Other Assets—Other assets primarily comprise unamortized deferred financing costs being
amortized over the life of the credit facility of five years, prepaid expenses, deposits on potential farm
acquisitions, deposits on trees to be acquired for development purposes and other miscellaneous
receivables.
We account for deferred offering costs in accordance with SEC Staff Accounting Bulletin ("SAW),
lbpic 5.A, which states that incremental costs directly attributable to a proposed or actual offering of
securities may properly be deferred and charged against the gross proceeds of the offering. Accordingly,
we record casts incurred related to public offerings of equity securities on our consolidated balance
sheet and pro-ratably apply these amounts to the proceeds of equity as stock is issued. The deferred
offering costs on our consolidated balance sheet as of December 31, 2014 will be applied to the
proceeds of equity in connection with our initial public offering ("IPO") in 2015.
F-36
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. R 6(e) DB-SDNY-0085839
CONFIDENTIAL SDNY_GM_00232023
EFTA01385012
ℹ️ Document Details
SHA-256
2ce0bbb78574e3b4b4893f3e514ac75e0d05de3928822524f43655e4bda33bb6
Bates Number
EFTA01385012
Dataset
DataSet-10
Type
document
Pages
1
💬 Comments 0